Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
3Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
FibroBiologics, Inc. (FBLG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
5Distinct source URLs
10High confidence
0.869Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
FibroBiologics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
H-C-WAINWRIGHT-CO-LLC
H-C-WAINWRIGHT-CO-LLC
92%
As previously disclosed, on May 1, 2026, FibroBiologics, Inc. (the “Company”) entered into that certain At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “…
UNITED-FIRE-CASUALTY-CO
UNITED-FIRE-CASUALTY-CO
92%
On April 3, 2026, FibroBiologics, Inc. (the “Company”) entered into a Sublease Buyout Agreement (the “Lease Termination Agreement”) with United Fire & Casualty Co. (doing business as United Fire Grou…
SPINALCYTE-LLC
SPINALCYTE-LLC
90%
In May 2021, as part our formation, we issued the equivalent of 8,750,000 shares of our Series A Preferred Stock to FibroGenesis in exchange for a Patent Assignment Agreement, which assigns certain p…
FIBROGENESIS
FIBROGENESIS
80%
In January 2023, we entered into an Agreement Regarding Right of First Negotiation with FibroGenesis, or the ROFN Agreement
FibroBiologics, Inc. Customers
Ticker
Name
Confidence
Evidence
FIBROGENESIS
FIBROGENESIS
90%
In July 2022, we loaned $300,000 to FibroGenesis at 0% interest and one year maturity date
YORKVILLE
YORKVILLE
90%
The Company may require the investor to purchase up to $ 10.0 million of shares of Common Stock by delivering written notice to the investor.
COMPANY-GOLDEN-KNIGHT-INCORPORATED
COMPANY-GOLDEN-KNIGHT-INCORPORATED
62%
r the three months ended March 31, 2026 and 2025 . Leases The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control th…
FibroBiologics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
FBLG-DEBT-9438
Warrants outstanding: 6.9
90%
xbrl warrant detail from xbrl 2026-03-31.
FBLG-DEBT
Debt stack $60,000
90%
Market cache reports total debt of $60,000.
FBLG-DEBT-9439
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
FibroBiologics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for FibroBiologics, Inc..
FibroBiologics, Inc. Ownership
Holder
Name
Confidence
Evidence
FBLG-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 3 tracked holders.
FibroBiologics, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
